Cons of GLP-1s: Potential side effects, high cost, and the need for continuous use
Strengths include transparent pricing, clear product images, research-use labeling, and third-party purity documentation
Recent cardiovascular outcome trials support the safety profile of GLP-1 agonists in patients with obesity and pre-diabetes
Even so, most cases of irregular bleeding arent serious and get better with the right treatment
Some GLP-1 treatments come as daily injections, while others are taken
Finally, the analysis of adverse events suggested that high-dose oral semaglutide was associated with a higher incidence of side effects in non-Asian patients, suggesting that physicians should pay close attention to gastrointestinal side effects during treatment in non-Asian T2DM patients